U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2022
358
Name Type Language
Mirvetuximab Soravtansine
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
mirvetuximab soravtansine [INN]
Common Name English
Immunoglobulin G1-kappa, anti-(human folate receptor alpha (adult folatebending protein, folate receptor 1, KB cells FBP, ovarian tumor-associated antigen Mov18)); humanized mouse monoclonal antibody linked to an average of four molecules of maytansine a
Common Name English
MIRVETUXIMAB SORAVTANSINE [USAN]
Common Name English
IMGN-853
Code English
Immunoglobulin G1, anti-(human folate receptor α) (human-Mus musculus monoclonal M9346A heavy chain), disulfide with human-Mus musculus monoclonal M9346A light chain, dimer, tetraamide with N2'-[4-[(3-carboxy-3- sulfopropyl)dithio]-4-methyl-1-oxopentyl]
Common Name English
IMGN853
Code English
Mirvetuximab soravtansine [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 435214
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
FDA ORPHAN DRUG 781620
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL2109414
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
CAS
1453084-37-1
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
DRUG BANK
DB12489
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
FDA UNII
98DE7VN88D
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
EVMPD
SUB181124
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
DAILYMED
98DE7VN88D
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
RXCUI
2621548
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
USAN
BC-78
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
PUBCHEM
91810695
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
NCI_THESAURUS
C102566
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
INN
10176
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
ChEMBL
CHEMBL3545132
Created by admin on Sat Dec 16 09:42:30 GMT 2023 , Edited by admin on Sat Dec 16 09:42:30 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966